{{Rsnum
|rsid=7240405
|Chromosome=18
|position=49632720
|Orientation=plus
|GMAF=0.129
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 31.9 | 65.5
| HCB | 0.0 | 20.4 | 79.6
| JPT | 1.8 | 18.6 | 79.6
| YRI | 0.0 | 20.4 | 79.6
| ASW | 3.5 | 22.8 | 73.7
| CHB | 0.0 | 20.4 | 79.6
| CHD | 0.9 | 24.1 | 75.0
| GIH | 1.0 | 19.8 | 79.2
| LWK | 0.9 | 10.0 | 89.1
| MEX | 0.0 | 8.6 | 91.4
| MKK | 1.3 | 17.3 | 81.4
| TSI | 2.9 | 22.5 | 74.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20031538
|Trait=HDL cholesterol
|Title=Genome-Wide Association Analysis of High-Density Lipoprotein Cholesterol in the Population-Based KORA Study Sheds New Light on Intergenic Regions
|RiskAllele=A
|Pval=5E-10
|OR=2.27
|ORtxt=[NR] mg/dl decrease
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{PMID Auto
|PMID=20018038
|Title=Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study.
|OA=1
}}

{{PMID Auto
|PMID=20370913
|Title=Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data.
|OA=1
}}

{{PMID Auto
|PMID=20502693
|Title=Genetics and beyond--the transcriptome of human monocytes and disease susceptibility.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}